Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;39(7):2067-2068.
doi: 10.1007/s10067-020-05184-3. Epub 2020 May 30.

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Kiana Vakil-Gilani  1 , Kenneth O'Rourke  2
Affiliations
Review

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Kiana Vakil-Gilani et al. Clin Rheumatol. 2020 Jul.
No abstract available

Keywords: COVID-19 disease severity; Chronic immunosuppressive therapy; Rheumatologic disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiology and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Antiga A (2020) Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transplant. 10.1002/lt.25756 - PubMed
    1. Monti S, Balduzzi A, Paolo D, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667–668. doi: 10.1136/annrheumdis-2020-217424. - DOI - PMC - PubMed
    1. Haberman R, Axelrad J, Chen A, Castillo R, Yan D, Izmirly P, Neimann A, Adhikari S, Hudesman D, Scher JU (2020) Covid-19 in immune-mediated inflammatory diseases — case series from New York. N Engl J Med https://www.nejm.org/doi/full/10.1056/NEJMc2009567 - DOI - PMC - PubMed
    1. Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020;215:108410. doi: 10.1016/j.clim.2020.108410. - DOI - PMC - PubMed

Substances

LinkOut - more resources